David Della Penta, Andrew Kellet, Gary Corsi, Bruce Bonnevier, Roland Heinrich, Gerard Willis, Eric Neumann, Ian Campbell, Molecular Devices, Genedata | GenomeWeb


Fisher Scientific International said this week that president and CEO David Della Penta will retire at the end of 2006. He will continue to be responsible for all of the company's operating activities until that time, Fisher said. Della Penta joined Fisher in April 1998.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.